The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents

被引：0
|
作者：
Honore, Patrick M. [1 ]
Mugisha, Aude [1 ]
Kugener, Luc [1 ]
Redant, Sebastien [1 ]
Attou, Rachid [1 ]
Gallerani, Andrea [1 ]
De Bels, David [1 ]
机构：
[1] Ctr Hosp Univ Brugmann, Brugmann Univ Hosp, ICU Dept, Pl Van Gehuchtenpl 4, B-1020 Brussels, Belgium
来源：
CRITICAL CARE | 2020年 / 24卷 / 01期
关键词：
BLOCKERS;
D O I：
10.1186/s13054-020-02947-x
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：2
相关论文
共 26 条
  • [1] The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
    Patrick M. Honore
    Aude Mugisha
    Luc Kugener
    Sebastien Redant
    Rachid Attou
    Andrea Gallerani
    David De Bels
    Critical Care, 24
  • [2] Neuromuscular blocking agents as part of lung-protective strategy in severe ARDS patients
    Papazian, Laurent
    Hraiech, Sami
    Cazenave, Laure
    Forel, Jean-Marie
    ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2019, 38 (04) : 311 - 313
  • [3] Prone positioning and neuromuscular blocking agents are part of standard care in severe ARDS patients: no
    Ferguson, Niall D.
    Thompson, B. Taylor
    INTENSIVE CARE MEDICINE, 2015, 41 (12) : 2198 - 2200
  • [4] Prone positioning and neuromuscular blocking agents are part of standard care in severe ARDS patients: no
    Niall D. Ferguson
    B. Taylor Thompson
    Intensive Care Medicine, 2015, 41 : 2198 - 2200
  • [5] Prone positioning and neuromuscular blocking agents are part of standard care in severe ARDS patients: yes
    Guerin, Claude
    Mancebo, Jordi
    INTENSIVE CARE MEDICINE, 2015, 41 (12) : 2195 - 2197
  • [6] Prone positioning and neuromuscular blocking agents are part of standard care in severe ARDS patients: yes
    Claude Guérin
    Jordi Mancebo
    Intensive Care Medicine, 2015, 41 : 2195 - 2197
  • [7] IMPACT OF NEUROMUSCULAR BLOCKADE INFUSION DURATION IN PATIENTS WITH MODERATE TO SEVERE ARDS
    Kuhrau, Shannon
    Chang, Kevin
    Lyons, John
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 462 - 462
  • [8] How I Use Neuromuscular Blocking Agents in ARDS Patients What are the modes of action supposed of the curares during the ARDS?
    Bourenne, J.
    Carvelli, J.
    Coiffard, B.
    Daviet, F.
    Parzy, G.
    Gainnier, M.
    Papazian, L.
    Hraiech, S.
    MEDECINE INTENSIVE REANIMATION, 2019, 28 (01): : 32 - 37
  • [9] Neuromuscular Blocking Agents for ARDS: Firm Evidence for ICU Mortality but Not for Long-Term Mortality
    Vargas, Maria
    Servillo, Giuseppe
    RESPIRATORY CARE, 2021, 66 (05) : 887 - 888
  • [10] A Survey of Academic Pulmonary and Critical Care Physician Use of Neuromuscular Blocking Agents in Patients with ARDS
    Dodia, N.
    Richert, M.
    Deitchman, A.
    Amariei, D.
    Shanholtz, C. B.
    Hasday, J. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
123